Rtw Investments »

Ceribell shares owned by Rtw Investments

Quarter-by-quarter ownership of Ceribell (CBLL) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Ceribell

Tip: Access up to 7 years of quarterly data

All positions including Ceribell held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ceribell by Rtw Investments

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.9M 150k 25.88

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Argenx Se Sponsored Adr (ARGX)
Natera (NTRA)
Axsome Therapeutics (AXSM)
Ptc Therapeutics I (PTCT)
Avidity Biosciences Ord (RNA)
Rocket Pharmaceuticals (RCKT)
Alkermes SHS (ALKS)
Stryker Corporation (SYK)
Protagonist Therapeutics (PTGX)
Insmed Com Par $.01 (INSM)
Penumbra (PEN)
Akero Therapeutics (AKRO)
Tarsus Pharmaceuticals (TARS)
Merus N V (MRUS)

View all positions for Rtw Investments

Top funds holding Ceribell

FMR
Tpg Gp A
Yu Fan
ABG-WTT Global Life Science Capital Partners GP
RA Capital Management
BlackRock
Vanguard Group
Board of Trustees of The Leland Stanford Junior University
Millennium Management
Franklin Resources
Redmile Group
Massachusetts Financial Services
Federated Investors
Novo A/S
Adage Capital Partners GP

View all funds holding Ceribell